美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Therapeutics

26.81

-0.5300-1.94%

盤後：26.810.00000.00%16:05 EDT

成交量：20.43萬

成交額：554.50萬

市值：7.55億

市盈率：-15.15

高：28.00

開：27.35

低：26.76

收：27.34

資料載入中...

總覽公司新聞公告

Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)股價飆升18.55% 市值漲1.03萬美元

摩根大通證券公司：維持Cidara Therapeutics(CDTX.US)評級，由優於大市調整至優於大市評級, 目標價由46.00美元調整至47.00美元。

Edgewise Therapeutics, Inc.盤中異動早盤大幅拉昇5.17%

Intensity Therapeutics, Inc.盤中異動股價大跌6.67%報0.530美元

4D Molecular Therapeutics, Inc.盤中異動早盤快速下跌5.25%報3.07美元

Tenaya Therapeutics, Inc.盤中異動股價大跌5.36%報0.417美元

花旗：維持Intellia Therapeutics(NTLA.US)評級，由中性調整至中性評級, 目標價由14.00美元調整至10.00美元。

Kazia Therapeutics Limited盤中異動快速拉昇6.13%

Cadrenal Therapeutics, Inc.盤中異動早盤股價大跌5.06%

Marker Therapeutics, Inc.盤中異動股價大跌5.81%

Relay Therapeutics, Inc.盤中異動早盤急速拉昇5.00%

Mink Therapeutics, Inc.盤中異動大幅上漲5.89%

Enliven Therapeutics, Inc.盤中異動早盤急速上漲5.07%

Alterity Therapeutics Limited盤中異動早盤快速拉昇5.20%

Carisma Therapeutics, Inc.股價重挫11.38% 市值跌42.09萬美元

Stoke Therapeutics, Inc.盤中異動急速拉昇5.30%

Sarepta Therapeutics, Inc.盤中異動股價大漲5.01%

Intellia Therapeutics, Inc.盤中異動快速上漲5.07%報8.70美元

Entrada Therapeutics, Inc.盤中異動早盤快速拉昇5.86%

Aclaris Therapeutics, Inc.盤中異動早盤快速上漲5.34%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LENZ/news?page=22"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":26.81,"timestamp":1747425600000,"preClose":27.34,"halted":0,"volume":204308,"hourTrading":{"tag":"盘后","latestPrice":26.81,"preClose":26.81,"latestTime":"16:05 EDT","volume":3732,"amount":100054.92,"timestamp":1747425913108},"delay":0,"floatShares":11814148,"shares":28146154,"eps":-1.769251,"marketStatus":"盤後交易","change":-0.53,"latestTime":"05-16 19:55:49 EDT","open":27.35,"high":28,"low":26.76,"amount":5545028.4806,"amplitude":0.045355,"askPrice":31.84,"askSize":100,"bidPrice":24.51,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1747440000000},"marketStatusCode":4,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":27.34,"postHourTrading":{"tag":"盘后","latestPrice":26.81,"preClose":26.81,"latestTime":"16:05 EDT","volume":3732,"amount":100054.92,"timestamp":1747425913108},"volumeRatio":1.153884,"impliedVol":0.6864,"impliedVolPercentile":0.8519},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":11814148,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":1.153884,"shares":28146154,"dividePrice":0,"high":28,"amplitude":0.045355,"preClose":27.34,"low":26.76,"week52Low":14.42,"pbRate":"3.93","week52High":38.93,"institutionHeld":0,"latestPrice":26.81,"eps":-1.769251,"divideRate":0,"volume":204308,"delay":0,"ttmEps":-1.769251,"open":27.35,"prevYearClose":28.87,"prevWeekClose":26.34,"prevMonthClose":28.515,"prevQuarterClose":25.71,"fiveDayClose":26.34,"twentyDayClose":23.82,"sixtyDayClose":24.94},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:22,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534743106","title":"Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)股價飆升18.55% 市值漲1.03萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534743106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534743106?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 23:14","pubTimestamp":1746803665,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日23时14分，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 股票出现波动，股价大幅上涨18.55%。Cero Therapeutics Holdings Inc C/Wts 13/02/2029 股票所在的生物技术行业中，整体跌幅为0.08%。Cero Therapeutics Holdings Inc C/Wts 13/02/2029 公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509231426a4785361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509231426a4785361&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CEROW","BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2534396044","title":"摩根大通證券公司：維持Cidara Therapeutics(CDTX.US)評級，由優於大市調整至優於大市評級, 目標價由46.00美元調整至47.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534396044","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534396044?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:56","pubTimestamp":1746802569,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Cidara Therapeutics(CDTX.US)评级，由优于大市调整至优于大市评级, 目标价由46.00美元调整至47.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09225650280382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159848","LENZ","CDTX","399975"],"gpt_icon":0},{"id":"2534436211","title":"Edgewise Therapeutics, Inc.盤中異動 早盤大幅拉昇5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534436211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534436211?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:45","pubTimestamp":1746801915,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时45分，Edgewise Therapeutics, Inc.股票出现异动，股价快速上涨5.17%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Phathom Pharmaceuticals, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Nucana Plc、Polyrizon Ltd.、Pasithea Therapeutics Corp.较为活跃，换手率分别为1068.82%、140.65%、27.54%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为129.76%、67.76%、56.12%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509224515a6d93ca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509224515a6d93ca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","EWTX","LENZ"],"gpt_icon":0},{"id":"2534436203","title":"Intensity Therapeutics, Inc.盤中異動 股價大跌6.67%報0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534436203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534436203?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:40","pubTimestamp":1746801608,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时40分，Intensity Therapeutics, Inc.股票出现波动，股价大幅下挫6.67%。截至发稿，该股报0.530美元/股，成交量3.0415万股，换手率0.20%，振幅3.15%。Intensity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Intensity Therapeutics, Inc.公司简介：Intensity Therapeutics Inc 是一家处于临床阶段的生物技术公司，开创了一种新的基于免疫的治疗实体瘤癌症的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509224008a4784be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509224008a4784be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","INTS","LENZ"],"gpt_icon":0},{"id":"2534245436","title":"4D Molecular Therapeutics, Inc.盤中異動 早盤快速下跌5.25%報3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534245436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534245436?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:37","pubTimestamp":1746801479,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时37分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅下挫5.25%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Phathom Pharmaceuticals, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Nucana Plc、Polyrizon Ltd.、Pasithea Therapeutics Corp.较为活跃，换手率分别为1041.30%、139.80%、25.97%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Phathom Pharmaceuticals, Inc.，振幅分别为129.76%、56.12%、56.11%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509223800aa2c8948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509223800aa2c8948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","FDMT","LENZ"],"gpt_icon":0},{"id":"2534439883","title":"Tenaya Therapeutics, Inc.盤中異動 股價大跌5.36%報0.417美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534439883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534439883?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:36","pubTimestamp":1746801368,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时36分，Tenaya Therapeutics, Inc.股票出现波动，股价急速下挫5.36%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗性疗法，解决心脏病的潜在驱动因素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050922360894f1e297&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050922360894f1e297&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TNYA","BK4539","BK4007"],"gpt_icon":0},{"id":"2534435702","title":"花旗：維持Intellia Therapeutics(NTLA.US)評級，由中性調整至中性評級, 目標價由14.00美元調整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534435702","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534435702?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:27","pubTimestamp":1746800864,"startTime":"0","endTime":"0","summary":"花旗：维持Intellia Therapeutics(NTLA.US)评级，由中性调整至中性评级, 目标价由14.00美元调整至10.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09222750280236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NTLA","LENZ"],"gpt_icon":0},{"id":"2534436780","title":"Kazia Therapeutics Limited盤中異動 快速拉昇6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534436780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534436780?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:26","pubTimestamp":1746800763,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时26分，Kazia Therapeutics Limited股票出现异动，股价大幅拉升6.13%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Phathom Pharmaceuticals, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Nucana Plc、Polyrizon Ltd.、Pasithea Therapeutics Corp.较为活跃，换手率分别为977.03%、138.82%、21.16%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Phathom Pharmaceuticals, Inc.，振幅分别为129.76%、56.12%、56.11%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050922260494f1e063&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050922260494f1e063&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","KZIA","NVGNF","LENZ","BK4539"],"gpt_icon":0},{"id":"2534435576","title":"Cadrenal Therapeutics, Inc.盤中異動 早盤股價大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534435576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534435576?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:24","pubTimestamp":1746800659,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时24分，Cadrenal Therapeutics, Inc.股票出现波动，股价大幅下挫5.06%。Cadrenal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Phathom Pharmaceuticals, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Nucana Plc、Polyrizon Ltd.、Pasithea Therapeutics Corp.较为活跃，换手率分别为958.29%、138.73%、20.56%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Phathom Pharmaceuticals, Inc.，振幅分别为129.76%、56.12%、56.11%。Cadrenal Therapeutics, Inc.公司简介：Cadrenal Therapeutics Inc正在开发其候选药物tecarfarin，以满足抗凝治疗中尚未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050922242094f1dff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050922242094f1dff5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVKD","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2534435169","title":"Marker Therapeutics, Inc.盤中異動 股價大跌5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534435169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534435169?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:10","pubTimestamp":1746799819,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时10分，Marker Therapeutics, Inc.股票出现异动，股价急速下挫5.81%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤学公司，专门从事用于治疗血液系统恶性肿瘤和实体瘤适应症的新型基于 T 细胞的免疫疗法和基于肽的疫苗的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505092210209754972b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505092210209754972b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","MRKR","BK4539"],"gpt_icon":0},{"id":"2534643510","title":"Relay Therapeutics, Inc.盤中異動 早盤急速拉昇5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534643510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534643510?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 22:02","pubTimestamp":1746799355,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日22时02分，Relay Therapeutics, Inc.股票出现异动，股价急速拉升5.00%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505092202359754954d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505092202359754954d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLAY","BK4539","BK4139","BK4007","LENZ","BK4563"],"gpt_icon":0},{"id":"2534438753","title":"Mink Therapeutics, Inc.盤中異動 大幅上漲5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534438753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534438753?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:53","pubTimestamp":1746798791,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时53分，Mink Therapeutics, Inc.股票出现波动，股价急速上涨5.89%。Mink Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Mink Therapeutics, Inc.公司简介：.MiNK Therapeutics Inc是一家临床阶段的生物制药公司，开创了异基因不变自然杀伤T细胞疗法的发现、开发和商业化，以治疗癌症和其他免疫介导的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509215312a6d93245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509215312a6d93245&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INKT","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2534436292","title":"Enliven Therapeutics, Inc.盤中異動 早盤急速上漲5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534436292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534436292?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:51","pubTimestamp":1746798679,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时51分，Enliven Therapeutics, Inc.股票出现异动，股价快速拉升5.07%。Enliven Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Celularity Inc C/Wts 16/07/2026 、Phathom Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为549.15%、128.72%、14.34%，振幅较大的相关个股有Phathom Pharmaceuticals, Inc.、Protalix Biotherapeutics, Inc. 、Carisma Therapeutics, Inc.，振幅分别为39.52%、22.15%、20.76%。Enliven Therapeutics, Inc.公司简介：Enliven Therapeutics Inc 是一家临床阶段的生物制药公司，专注于小分子治疗药物的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509215119aa2c8915&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509215119aa2c8915&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","ELVN","BK4139"],"gpt_icon":0},{"id":"2534384984","title":"Alterity Therapeutics Limited盤中異動 早盤快速拉昇5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534384984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534384984?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:49","pubTimestamp":1746798597,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时49分，Alterity Therapeutics Limited股票出现波动，股价大幅上涨5.20%。Alterity Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Celularity Inc C/Wts 16/07/2026 、Phathom Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为543.39%、128.69%、13.67%，振幅较大的相关个股有Phathom Pharmaceuticals, Inc.、Protalix Biotherapeutics, Inc. 、艾切托，振幅分别为39.52%、22.15%、19.13%。Alterity Therapeutics Limited公司简介：Alterity Therapeutics Ltd 活跃在医疗保健领域。该集团经营单一的部门，即帕金森病和其他神经退行性疾病的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214957a6d9318c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214957a6d9318c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","PRNAF","ATHE","BK4539","LENZ"],"gpt_icon":0},{"id":"2534543829","title":"Carisma Therapeutics, Inc.股價重挫11.38% 市值跌42.09萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534543829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534543829?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:49","pubTimestamp":1746798567,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时49分，Carisma Therapeutics, Inc.股票出现波动，股价急速跳水11.38%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214928a6d9316e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214928a6d9316e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2534048078","title":"Stoke Therapeutics, Inc.盤中異動 急速拉昇5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534048078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534048078?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:49","pubTimestamp":1746798550,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时49分，Stoke Therapeutics, Inc.股票出现异动，股价快速上涨5.30%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Celularity Inc C/Wts 16/07/2026 、Phathom Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为537.96%、128.68%、13.58%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Phathom Pharmaceuticals, Inc.、Protalix Biotherapeutics, Inc. ，振幅分别为76.90%、39.52%、22.15%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 是一家致力于利用 RNA 医药开发来恢复蛋白质表达的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214910a6d93142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214910a6d93142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","STOK","BK4139","LENZ"],"gpt_icon":0},{"id":"2534648078","title":"Sarepta Therapeutics, Inc.盤中異動 股價大漲5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534648078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534648078?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:47","pubTimestamp":1746798434,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时47分，Sarepta Therapeutics, Inc.股票出现异动，股价快速拉升5.01%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。该信息摘要如下：高盛：维持Sarepta Therapeutics评级，由买入调整至买入评级, 目标价由178.00美元调整至100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214714a47840da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214714a47840da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","IE00BJJMRZ35.SGD","IE0009355771.USD","LENZ","BK4007","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4585","SRPT","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4139"],"gpt_icon":0},{"id":"2534480404","title":"Intellia Therapeutics, Inc.盤中異動 快速上漲5.07%報8.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534480404?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:45","pubTimestamp":1746798339,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时45分，Intellia Therapeutics, Inc.股票出现异动，股价急速上涨5.07%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214540aa2c890b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214540aa2c890b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4007","BK4139","NTLA","LU1861558580.USD","BK4585","BK4588","BK4535","LENZ","LU1861559042.SGD","BK4539"],"gpt_icon":0},{"id":"2534761480","title":"Entrada Therapeutics, Inc.盤中異動 早盤快速拉昇5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534761480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534761480?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:44","pubTimestamp":1746798264,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时44分，Entrada Therapeutics, Inc.股票出现异动，股价快速拉升5.86%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214432a4784025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214432a4784025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRDA","BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2534438487","title":"Aclaris Therapeutics, Inc.盤中異動 早盤快速上漲5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534438487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534438487?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 21:44","pubTimestamp":1746798249,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时44分，Aclaris Therapeutics, Inc.股票出现波动，股价大幅上涨5.34%。Aclaris Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Celularity Inc C/Wts 16/07/2026 、Phathom Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为521.51%、124.20%、12.71%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Phathom Pharmaceuticals, Inc.、Protalix Biotherapeutics, Inc. ，振幅分别为76.90%、30.79%、18.18%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921440994f1d7c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921440994f1d7c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":35,"pageCount":22,"totalSize":695,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"LENZ","fiscalQuarterEnding":"2025/03","expectedEps":-0.55,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.53},{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"盤前","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-05-15","current":-16.289867,"percent":0.033708,"low":-17.315721,"twenty":-14.238844,"median":-10.134479,"eighty":-6.45989,"high":-5.069183,"avg":-10.370641,"sd":3.381091,"marketCap":777678235},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-15","current":-16.289867,"twenty":-14.238844,"median":-10.134479,"eighty":-6.45989,"marketCap":777678235}],"updateTime":1747403249642}}}